Skip to main content
logo
Frontier Biotechnologies Inc. (SHA:688221)
China flag China · Delayed Price · Currency is CNY
16.87
+0.45 (2.74%)
At close: Sep 30, 2026

Frontier Biotechnologies Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6,3196,7613,6563,7166,4656,688
Market Cap Growth
17.15%84.94%-1.61%-42.53%-3.33%-3.43%
Enterprise Value
5,8326,4433,4423,0555,3915,318
Last Close Price
16.8718.059.769.9217.2618.59

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
16.7254.8028.2432.5276.29165.12
PB Ratio
6.117.713.202.773.873.65
P/TBV Ratio
6.869.023.693.344.574.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
15.4352.2226.5926.7463.61131.30

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.410.460.360.280.170.16
Net Debt / Equity Ratio
-0.47-0.35-0.39-0.42-0.58-0.65
Net Debt / EBITDA Ratio
32.151.301.871.862.734.19
Net Debt / FCF Ratio
-11.331.202.321.422.242.08
Asset Turnover
0.220.070.070.050.030.02
Inventory Turnover
1.521.581.911.421.471.91
Quick Ratio
4.472.212.812.654.643.76
Current Ratio
4.962.453.092.905.073.95
Return on Equity (ROE)
-2.10%-26.56%-16.21%-21.83%-20.38%-13.36%
Return on Assets (ROA)
-1.20%-9.59%-8.76%-9.45%-10.08%-7.95%
Return on Capital Employed (ROCE)
-2.20%-22.30%-19.50%-19.60%-18.70%-15.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.34%-3.96%-5.51%-8.85%-5.52%-3.89%
FCF Yield
0.68%-3.79%-5.23%-10.67%-6.64%-8.53%
Buyback Yield / Dilution
0.62%0.17%0.24%-2.69%-0.79%-25.23%